Freedom Stock Rockets 8.2% With 7-Day Winning Streak
Freedom (FRHC) – a retail securities brokerage and investment banking service provider – hit a 7-day winning streak, with cumulative gains over this period amounting to 8.2%. The company’s market cap has surged by about $642 Mil over the last 7 days and currently stands at $8.5 Bil.
Is this opportunity or trap? There is a near-equal mix of good and bad in FRHC stock given its overall Moderate operating performance and financial condition. Hence, despite its Moderate valuation, this makes the stock look Risky (For details, see Buy or Sell FRHC).
But here is the interesting part. You are reading about this 8.2% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. High Quality Portfolio is based on an architecture that includes such signals.
Returns vs S&P 500
- Merck Stock Pays Out $53 Bil – Investors Take Note
- Chevron Stock Hands $123 Bil Back – Worth a Look?
- Years of Rewards: $53 Bil From Coca-Cola Stock
- Intuitive Surgical Stock Near Crucial Support – Buy Signal?
- FactSet Research Systems Stock Pulls Back to Support – Smart Entry?
- Veeva Systems Stock Delivers Strong Cash Yield – Upside Ahead?
The following table summarizes the return for FRHC stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | FRHC | S&P 500 |
|---|---|---|
| 1D | 1.3% | -0.4% |
| 7D (Current Streak) | 8.2% | -1.1% |
| 1M (21D) | 21.3% | -4.1% |
| 3M (63D) | 4.8% | -4.1% |
| YTD 2026 | 17.4% | -4.2% |
| 2025 | -6.9% | 16.4% |
| 2024 | 62.1% | 23.3% |
| 2023 | 38.4% | 24.2% |
However, big gains can follow sharp reversals – but how has FRHC behaved after prior drops? See FRHC Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 45 S&P constituents with 3 days or more of consecutive gains and 42 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 19 | 20 |
| 4D | 22 | 4 |
| 5D | 0 | 8 |
| 6D | 2 | 7 |
| 7D or more | 2 | 3 |
| Total >=3 D | 45 | 42 |
Key Financials for Freedom (FRHC)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $1.7 Bil | $2.0 Bil |
| Operating Income | $926.8 Mil | $631.8 Mil |
| Net Income | $375.5 Mil | $84.7 Mil |
Last 2 Fiscal Quarters:
| Metric | 2026 FQ2 | 2026 FQ3 |
|---|---|---|
| Revenues | $530.9 Mil | $615.6 Mil |
| Operating Income | $159.7 Mil | $200.0 Mil |
| Net Income | $38.7 Mil | $76.2 Mil |
While FRHC stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.